Vitamin C is widely known as a water-soluble antioxidant vitamin, but when high concentrations are reached via IV drip, specific effects not obtainable through ordinary oral intake appear.
A comprehensive recent review (2025) by a surgical team at Capital Medical University (Beijing) analyzing over 150 prior studies. It establishes that pharmacological blood concentrations of vitamin C (20-30 mM) can only be achieved through intravenous administration, and organizes the four anti-tumor mechanisms that operate at this concentration, described below. It also notes that clinical data is accumulating showing the potential for reduced side effects (such as fatigue and gastrointestinal symptoms) and improved quality of life when combined with chemotherapy or radiotherapy, while concluding that larger trials are still needed regarding optimal dose, administration method, and patient selection.
Reports unexpected long-term survival or tumor shrinkage observed after high-dose vitamin C IV therapy in three cases of kidney cancer, bladder cancer, and B-cell lymphoma. A pioneering case report discussing its supportive role alongside standard treatment.
The safety and tolerability of high-dose vitamin C IV drip have been confirmed in multiple Phase I/II trials, with potential for improved quality of life and reduced side effects when combined with chemotherapy. It also organizes the mechanism by which it acts selectively on cancer cells without toxicity to normal cells.
The dose is selected according to your goals. For cosmetic and immune-boosting purposes, 25g is typical; for supportive cancer care, 50-75g administered once or twice a week is typical. Before high-dose administration (50g or more), a test for G6PD (glucose-6-phosphate dehydrogenase) deficiency is required (first time only).
On your first visit, we will ask about your goals, current treatment status, and medications during the interview. If you wish to receive 50g or more, a G6PD test (blood draw) will be done first.
For those visiting for supportive cancer care, bringing your current physician's treatment plan and test data allows us to make more specific recommendations. We also welcome consultations from those who find it difficult to discuss this with their primary physician.
Combination with other IV drips is also possible.
Please feel free to contact us first about supportive cancer care, beauty, or immune support.
๐ 088-856-7511